Back to search
FDAFDA · Food and drugs·Recall number D-0840-2016

Paliperidone Extended-release Tablets, 1.5 mg, 30 count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV --- NDC 0378-3978-93

Published May 18, 2016 · Recall initiated: February 12, 2016

Summary

FDA records drug Class II recall D-0840-2016, published May 18, 2016 and initiated February 12, 2016. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 2928 bottles; Lot: Lot: 2005441, 01/2017, Code: 0378-3978-93. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications; three month stability time point.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
Nationwide
Lot
Lot: 2005441, 01/2017, Code: 0378-3978-93
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Paliperidone Extended-release Tablets, 1.5 mg, 30 count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV --- NDC 0378-3978-93 recalled?

Yes. FDA published recall D-0840-2016 on May 18, 2016. Reported hazard: Failed Dissolution Specifications; three month stability time point.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail